Department of Medicine

November 15, 2018

Benefits of smoking cessation take time: study

People who quit smoking see their risk of cardiovascular disease immediately begin to drop, but it may take up to 16 years for their health to reach the level of someone who has never smoked, according to a new Vanderbilt study.

By Matt Batcheldor
November 15, 2018

Harrison awarded AHA Basic Research Prize for 2018

David G. Harrison, MD, the Betty and Jack Bailey Professor of Cardiology and director of the Division of Clinical Pharmacology at Vanderbilt University School of Medicine, has been awarded the American Heart Association’s Basic Research Prize for 2018.

By Bill Snyder
November 8, 2018

Vitamin C protects brain from seizures

Brain ascorbate — vitamin C — is important for protecting the brain against seizures and cognitive decline in Alzheimer’s disease.

By Nora Foegeding
November 8, 2018

New clinic focused on caring for vasculitis patients

Vanderbilt University Medical Center recently debuted a new clinic dedicated to providing a multidisciplinary approach to caring for patients coping with the complex host of chronic disorders known as vasculitis.

By Doug Campbell
November 8, 2018

Clinical fellows program bolstered by new NCI grant

A new grant from the National Cancer Institute (NCI) will fund an intensively mentored training experience for clinical fellows at Vanderbilt University Medical Center for the next five years.

By Tom Wilemon
October 26, 2018

Clues to bone metastases

Vanderbilt researchers are developing new approaches to study the mechanisms underlying why breast cancer cells home to bone and lie dormant, evading treatment.

By Sanjay Mishra
October 26, 2018

Fetal membranes and microbial threats

Understanding how cells communicate in the membranes surrounding the developing fetus could suggest new strategies for preventing infections, premature birth and adverse pregnancy outcomes.
By Leigh MacMillan
October 22, 2018

Antipsychotics ineffective for treating ICU delirium: study

Critically ill patients are not benefiting from antipsychotic medications that have been used to treat delirium in intensive care units (ICUs) for more than four decades, according to a study released today in the New England Journal of Medicine.
By Craig Boerner
October 12, 2018

Targeting diabetic kidney disease

Pathways activated by the epidermal growth factor receptor may be attractive targets to treat diabetic kidney disease, according to new findings from Vanderbilt investigators.
By Sanjay Mishra
October 11, 2018

Novel genetic study sheds new light on risk of heart attack

Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife.
By Bill Snyder
October 11, 2018

Cancer Center investigators awarded Komen grants

Four Vanderbilt-Ingram Cancer Center (VICC) investigators have received financial support from Susan G. Komen for breast cancer research.
By Tom Wilemon
October 11, 2018

Team’s study reveals hidden lives of medical biomarkers

What do medical biomarkers do on evenings and weekends, when they might be considered off the clock?
By Paul Govern
October 4, 2018

New center formed to treat, study ICU delirium, dementia

Millions of patients in intensive care units each year develop delirium during their hospitalization and often leave the hospital with cognitive deficits similar to those suffering from traumatic brain injury or mild Alzheimer’s disease.
By Nancy Humphrey
1 … 70 71 72 73 74 … 116